Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Overview of SARS-CoV-2 infection in adults living with HIV.
Ambrosioni J, Blanco JL, Reyes-Urueña JM, Davies MA, Sued O, Marcos MA, Martínez E, Bertagnolio S, Alcamí J, Miro JM; COVID-19 in HIV Investigators. Ambrosioni J, et al. Among authors: bertagnolio s. Lancet HIV. 2021 May;8(5):e294-e305. doi: 10.1016/S2352-3018(21)00070-9. Lancet HIV. 2021. PMID: 33915101 Free PMC article. Review.
Clinical features of, and risk factors for, severe or fatal COVID-19 among people living with HIV admitted to hospital: analysis of data from the WHO Global Clinical Platform of COVID-19.
Bertagnolio S, Thwin SS, Silva R, Nagarajan S, Jassat W, Fowler R, Haniffa R, Reveiz L, Ford N, Doherty M, Diaz J. Bertagnolio S, et al. Lancet HIV. 2022 Jul;9(7):e486-e495. doi: 10.1016/S2352-3018(22)00097-2. Epub 2022 May 10. Lancet HIV. 2022. PMID: 35561704 Free PMC article.
Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis.
Gupta RK, Jordan MR, Sultan BJ, Hill A, Davis DH, Gregson J, Sawyer AW, Hamers RL, Ndembi N, Pillay D, Bertagnolio S. Gupta RK, et al. Among authors: bertagnolio s. Lancet. 2012 Oct 6;380(9849):1250-8. doi: 10.1016/S0140-6736(12)61038-1. Epub 2012 Jul 23. Lancet. 2012. PMID: 22828485 Free PMC article.
HIV Drug Resistance.
Bertagnolio S, Jordan MR, Doherty M. Bertagnolio S, et al. N Engl J Med. 2018 Mar 1;378(9):874. doi: 10.1056/NEJMc1716089. N Engl J Med. 2018. PMID: 29504388 No abstract available.
Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelines.
Phillips AN, Bansi-Matharu L, Venter F, Havlir D, Pozniak A, Kuritzkes DR, Wensing A, Lundgren JD, Pillay D, Mellors J, Cambiano V, Jahn A, Apollo T, Mugurungi O, Ripin D, Da Silva J, Raizes E, Ford N, Siberry GK, Gupta RK, Barnabas R, Revill P, Cohn J, Calmy A, Bertagnolio S. Phillips AN, et al. Among authors: bertagnolio s. Lancet HIV. 2020 Mar;7(3):e193-e200. doi: 10.1016/S2352-3018(19)30400-X. Epub 2020 Feb 5. Lancet HIV. 2020. PMID: 32035041 Free PMC article.
Guidelines are needed for studies of pre-treatment HIV drug resistance: a methodological study.
Mbuagbaw L, Ongolo-Zogo C, Mendoza OC, Zani B, Morfaw F, Nyambi A, Wang A, Kiflen M, El-Kechen H, Leenus A, Youssef M, Rehman N, Hermans L, MacDonald V, Bertagnolio S. Mbuagbaw L, et al. Among authors: bertagnolio s. BMC Med Res Methodol. 2021 Apr 19;21(1):76. doi: 10.1186/s12874-021-01258-1. BMC Med Res Methodol. 2021. PMID: 33874897 Free PMC article.
119 results